We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DNTH market cap is 591.94M. The company's latest EPS is USD -1.4716 and P/E is -13.61.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.37M | 457k | 874k | 1.86M | 2.17M |
| Operating Income | -15.63M | -12.96M | -17.84M | -22.2M | -29.9M |
| Net Income | -538k | -10.56M | -13.75M | -17.61M | -25.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 2.83M |
| Operating Income | -82.97M | -78.7M | -74.69M | -80.9M | -48.17M |
| Net Income | -76.77M | -74.94M | -71.14M | -76.46M | -43.56M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 192.46M | 179.41M | 382.46M | 368.96M | 354.25M |
| Total Liabilities | 14.08M | 10.54M | 9.78M | 10.74M | 16.35M |
| Total Equity | 178.38M | 168.87M | 372.69M | 358.22M | 337.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 161.51M | 161.62M | 189.93M | 146.65M | 179.41M |
| Total Liabilities | 20.32M | 17.71M | 17.26M | 40.69M | 10.54M |
| Total Equity | 141.19M | 143.91M | 172.67M | 105.96M | 168.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.01M | -36.86M | -14.94M | -29.47M | -50.74M |
| Investing | 28.49M | 20.25M | -5.51M | -4.34M | -263.7M |
| Financing | 138.44M | 133.57M | 217.85M | 215.65M | 215.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57.1M | -64.02M | -59.53M | -67.09M | -36.86M |
| Investing | 1.53M | -10.64M | 43.43M | -9.81M | 20.25M |
| Financing | 62.3M | 67.74M | 89.6M | 2.88M | 133.57M |
| Market Cap | 591.94M |
| Price to Earnings Ratio | -13.61 |
| Price to Sales Ratio | 209.74 |
| Price to Cash Ratio | 4.48 |
| Price to Book Ratio | 3.51 |
| Dividend Yield | - |
| Shares Outstanding | 29.6M |
| Average Volume (1 week) | 374.79k |
| Average Volume (1 Month) | 300.6k |
| 52 Week Change | 64.61% |
| 52 Week High | 33.77 |
| 52 Week Low | 10.65 |
| Spread (Intraday) | 1.8 (8.45%) |
| Company Name | Dianthus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.magentatx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
